Anick Auger

Company: Ventus Therapeutics

Job title: Senior Director, Head of Pharmacology

Seminars:

Panel Discussion: Assessing the Current Landscape of Inflammasome Therapeutics to Identify the Bottlenecks, Key Field Considerations, & Debating the Future of Inhibitors/Activators 3:30 pm

Looking outside of NLRP3: Which inflammasome do we think is going to be the next go-to? And will it be disease-specific? Exploring upstream targets of inflammatory processes: Diving into downstream targets of inflammasome activation to complete the picture: Understanding the key limitations of preclinical models to move forward: Which models do big pharma want to…Read more

day: Conf Day 2

NLRP3 Inhibitor to Treat Neuroinflammatory & Neurodegenerative Diseases: From Discovery to Development 9:00 am

Session Overview to Be ConfirmedRead more

day: Conf Day 2